Acute Respiratory Failure and Pulmonary Complications in End-Stage Liver Disease

Nida Qadir; Tisha Wang; Igor Barjaktarevic; Steven Y. Chang

doi:10.1055/s-0038-1673638

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2018; 39(05): 546-555
DOI: 10.1055/s-0038-1673638

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Acute Respiratory Failure and Pulmonary Complications in End-Stage Liver Disease

Authors

Nida Qadir

¹Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
Tisha Wang

¹Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
Igor Barjaktarevic

¹Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
Steven Y. Chang

¹Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California

Abstract

Acute respiratory failure has a high mortality in patients with end-stage liver disease (ESLD). These patients may develop acute respiratory failure for reasons specific to advanced liver disease, including hepatopulmonary syndrome, portopulmonary hypertension, and hepatic hydrothorax. They may also develop respiratory complications due to conditions seen in the general intensive care unit population to which ESLD patients are at higher risk, including infection, volume overload, and the acute respiratory distress syndrome. Management of these patients is complicated and multifaceted, and a comprehensive understanding of the etiologies and treatment of acute respiratory failure is critical in this high-risk patient population. This article reviews current evidence surrounding the prevalence, management, and complications of the various etiologies of acute respiratory failure in ESLD patients.

Keywords

acute respiratory failure - end-stage liver disease - liver transplantation - cirrhosis - acute liver failure - hepatopulmonary syndrome - portopulmonary hypertension - hepatic hydrothorax

Full Text

References

References
1 Cosarderelioglu C, Cosar AM, Gurakar M, Dagher NN, Gurakar A. Hepatopulmonary syndrome and liver transplantation: a recent review of the literature. J Clin Transl Hepatol 2016; 4 (01) 47-53
2 Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 2005; 41 (05) 1122-1129
3 Iyer VN, Swanson KL, Cartin-Ceba R. , et al. Hepatopulmonary syndrome: favorable outcomes in the MELD exception era. Hepatology 2013; 57 (06) 2427-2435
4 Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology 2006; 44 (06) 1502-1510
5 Colle IO, Moreau R, Godinho E. , et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology 2003; 37 (02) 401-409
6 Castro M, Krowka MJ, Schroeder DR. , et al. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc 1996; 71 (06) 543-551
7 Krowka MJ, Miller DP, Barst RJ. , et al. Portopulmonary hypertension: a report from the US-based REVEAL Registry. Chest 2012; 141 (04) 906-915
8 Sithamparanathan S, Nair A, Thirugnanasothy L. , et al; National Pulmonary Hypertension Service Research Collaboration of the United Kingdom and Ireland. Survival in portopulmonary hypertension: outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry. J Heart Lung Transplant 2017; 36 (07) 770-779
9 Verma S, Hand F, Armstrong MJ. , et al. Portopulmonary hypertension: still an appropriate consideration for liver transplantation?. Liver Transpl 2016; 22 (12) 1637-1642
10 Roussos A, Philippou N, Mantzaris GJ, Gourgouliannis KI. Hepatic hydrothorax: pathophysiology diagnosis and management. J Gastroenterol Hepatol 2007; 22 (09) 1388-1393
11 Hung TH, Tseng CW, Tsai CC, Tsai CC, Tseng KC, Hsieh YH. The long-term outcomes of cirrhotic patients with pleural effusion. Saudi J Gastroenterol 2018; 24 (01) 46-51
12 Rodríguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome--a liver-induced lung vascular disorder. N Engl J Med 2008; 358 (22) 2378-2387
13 Seward JB, Hayes DL, Smith HC. , et al. Platypnea-orthodeoxia: clinical profile, diagnostic workup, management, and report of seven cases. Mayo Clin Proc 1984; 59 (04) 221-231
14 Mohammad Alizadeh AH, Fatemi SR, Mirzaee V. , et al. Clinical features of hepatopulmonary syndrome in cirrhotic patients. World J Gastroenterol 2006; 12 (12) 1954-1956
15 Cremona G, Higenbottam TW, Mayoral V. , et al. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J 1995; 8 (11) 1883-1885
16 Zhang J, Luo B, Tang L. , et al. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology 2009; 136 (03) 1070-1080
17 Zhang HY, Han DW, Wang XG, Zhao YC, Zhou X, Zhao HZ. Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome. World J Gastroenterol 2005; 11 (04) 567-572
18 Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995; 109 (04) 1283-1288
19 Abrams GA, Nanda NC, Dubovsky EV, Krowka MJ, Fallon MB. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 1998; 114 (02) 305-310
20 Fallon MB, Mulligan DC, Gish RG, Krowka MJ. Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome. Liver Transpl 2006; 12 (12) , suppl (Suppl. 03) S105 –S107
21 Abrams GA, Fallon MB. Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): a pilot trial. J Clin Gastroenterol 1998; 27 (03) 232-235
22 De BK, Dutta D, Pal SK, Gangopadhyay S, Das Baksi S, Pani A. The role of garlic in hepatopulmonary syndrome: a randomized controlled trial. Can J Gastroenterol 2010; 24 (03) 183-188
23 Tanikella R, Philips GM, Faulk DK, Kawut SM, Fallon MB. Pilot study of pentoxifylline in hepatopulmonary syndrome. Liver Transpl 2008; 14 (08) 1199-1203
24 Gupta LB, Kumar A, Jaiswal AK. , et al. Pentoxifylline therapy for hepatopulmonary syndrome: a pilot study. Arch Intern Med 2008; 168 (16) 1820-1823
25 Gupta S, Castel H, Rao RV. , et al. Improved survival after liver transplantation in patients with hepatopulmonary syndrome. Am J Transplant 2010; 10 (02) 354-363
26 Kawut SM, Krowka MJ, Trotter JF. , et al; Pulmonary Vascular Complications of Liver Disease Study Group. Clinical risk factors for portopulmonary hypertension. Hepatology 2008; 48 (01) 196-203
27 Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991; 100 (02) 520-528
28 DuBrock HM, Goldberg DS, Sussman NL. , et al. Predictors of waitlist mortality in portopulmonary hypertension. Transplantation 2017; 101 (07) 1609-1615
29 Savale L, Sattler C, Coilly A. , et al. Long-term outcome in liver transplantation candidates with portopulmonary hypertension. Hepatology 2017; 65 (05) 1683-1692
30 Krowka MJ, Fallon MB, Kawut SM. , et al. International Liver Transplant Society Practice Guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation 2016; 100 (07) 1440-1452
31 DeMartino ES, Cartin-Ceba R, Findlay JY, Heimbach JK, Krowka MJ. Frequency and outcomes of patients with increased mean pulmonary artery pressure at the time of liver transplantation. Transplantation 2017; 101 (01) 101-106
32 Salgia RJ, Goodrich NP, Simpson H, Merion RM, Sharma P. Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era. Dig Dis Sci 2014; 59 (08) 1976-1982
33 OPTN National Data. Available at: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/# . Accessed on: June 15, 2018
34 Badillo R, Rockey DC. Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature. Medicine (Baltimore) 2014; 93 (03) 135-142
35 Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med 1999; 107 (03) 262-267
36 Bonacini M, Rammohan G. 99mTc-sulfur colloid studies in hepatic hydrothorax. Gastroenterology 1987; 92 (01) 273
37 Ajmi S, Hassine H, Guezguez M. , et al. Isotopic exploration of hepatic hydrothorax: ten cases. Gastroenterol Clin Biol 2004; 28 (05) 462-466
38 Benet A, Vidal F, Toda R, Siurana R, De Virgala CM, Richart C. Diagnosis of hepatic hydrothorax in the absence of ascites by intraperitoneal injection of 99m-Tc-Fluor colloid. Postgrad Med J 1992; 68 (796) 153
39 Raju EP, Rao PN, Venkateswarlu J, Subhashini S. Ultrasound documentation of diaphragmatic rent in hepatic hydrothorax. Indian J Gastroenterol 1989; 8 (02) 111-112
40 Foschi FG, Piscaglia F, Pompili M. , et al. Real-time contrast-enhanced ultrasound--a new simple tool for detection of peritoneal-pleural communications in hepatic hydrothorax. Ultraschall Med 2008; 29 (05) 538-542
41 Tamano M, Hashimoto T, Kojima K, Maeda C, Hiraishi H. Diagnosis of hepatic hydrothorax using contrast-enhanced ultrasonography with intraperitoneal injection of Sonazoid. J Gastroenterol Hepatol 2010; 25 (02) 383-386
42 Runyon BA, Greenblatt M, Ming RH. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol 1986; 81 (07) 566-567
43 Orman ES, Lok AS. Outcomes of patients with chest tube insertion for hepatic hydrothorax. Hepatol Int 2009; 3 (04) 582-586
44 Porcel JM. Management of refractory hepatic hydrothorax. Curr Opin Pulm Med 2014; 20 (04) 352-357
45 Xiol X, Castellote J, Cortes-Beut R, Delgado M, Guardiola J, Sesé E. Usefulness and complications of thoracentesis in cirrhotic patients. Am J Med 2001; 111 (01) 67-69
46 Garcia Jr N, Mihas AA. Hepatic hydrothorax: pathophysiology, diagnosis, and management. J Clin Gastroenterol 2004; 38 (01) 52-58
47 Tu CY, Chen CH. Spontaneous bacterial empyema. Curr Opin Pulm Med 2012; 18 (04) 355-358
48 Chen CH, Shih CM, Chou JW. , et al. Outcome predictors of cirrhotic patients with spontaneous bacterial empyema. Liver Int 2011; 31 (03) 417-424
49 Xiol X, Castellví JM, Guardiola J. , et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology 1996; 23 (04) 719-723
50 Castellote J, Gornals J, Lopez C, Xiol X. Acute tension hydrothorax: a life-threatening complication of cirrhosis. J Clin Gastroenterol 2002; 34 (05) 588-589
51 Okuyama T, Kimura M, Uchida J. , et al. Porous diaphragm syndrome with repeated rapid accumulation of pleural effusion. Intern Med 2014; 53 (10) 1075-1077
52 Leung AN, Müller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 1990; 154 (03) 487-492
53 Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol 2014; 61 (06) 1385-1396
54 TenHoor T, Mannino DM, Moss M. Risk factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study. Chest 2001; 119 (04) 1179-1184
55 Matuschak GM, Rinaldo JE. Organ interactions in the adult respiratory distress syndrome during sepsis. Role of the liver in host defense. Chest 1988; 94 (02) 400-406
56 Rabe C, Schmitz V, Paashaus M. , et al. Does intubation really equal death in cirrhotic patients? Factors influencing outcome in patients with liver cirrhosis requiring mechanical ventilation. Intensive Care Med 2004; 30 (08) 1564-1571
57 Zimmerman JE, Wagner DP, Seneff MG, Becker RB, Sun X, Knaus WA. Intensive care unit admissions with cirrhosis: risk-stratifying patient groups and predicting individual survival. Hepatology 1996; 23 (06) 1393-1401
58 Levesque E, Saliba F, Ichaï P, Samuel D. Outcome of patients with cirrhosis requiring mechanical ventilation in ICU. J Hepatol 2014; 60 (03) 570-578
59 Lai CC, Ho CH, Cheng KC, Chao CM, Chen CM, Chou W. Effect of liver cirrhosis on long-term outcomes after acute respiratory failure: a population-based study. World J Gastroenterol 2017; 23 (12) 2201-2208
60 Juneja D, Gopal PB, Kapoor D, Raya R, Sathyanarayanan M. Profile and outcome of patients with liver cirrhosis requiring mechanical ventilation. J Intensive Care Med 2012; 27 (06) 373-378
61 Ni YN, Luo J, Yu H. , et al. Can high-flow nasal cannula reduce the rate of endotracheal intubation in adult patients with acute respiratory failure compared with conventional oxygen therapy and noninvasive positive pressure ventilation? A systematic review and meta-analysis. Chest 2017; 151 (04) 764-775
62 Helviz Y, Einav S. A systematic review of the high-flow nasal cannula for adult patients. Crit Care 2018; 22 (01) 71
63 Leeies M, Flynn E, Turgeon AF. , et al. High-flow oxygen via nasal cannulae in patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis. Syst Rev 2017; 6 (01) 202
64 Zhu Y, Yin H, Zhang R, Wei J. High-flow nasal cannula oxygen therapy versus conventional oxygen therapy in patients with acute respiratory failure: a systematic review and meta-analysis of randomized controlled trials. BMC Pulm Med 2017; 17 (01) 201
65 Corley A, Rickard CM, Aitken LM. , et al. High-flow nasal cannulae for respiratory support in adult intensive care patients. Cochrane Database Syst Rev 2017; 5: CD010172
66 Rochwerg B, Brochard L, Elliott MW. , et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017; 50 (02) 50
67 Barr J, Fraser GL, Puntillo K. , et al; American College of Critical Care Medicine. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013; 41 (01) 263-306
68 Lonardo NW, Mone MC, Nirula R. , et al. Propofol is associated with favorable outcomes compared with benzodiazepines in ventilated intensive care unit patients. Am J Respir Crit Care Med 2014; 189 (11) 1383-1394
69 Girard TD, Alhazzani W, Kress JP. , et al; ATS/CHEST Ad Hoc Committee on Liberation from Mechanical Ventilation in Adults. An Official American Thoracic Society/American College of Chest Physicians Clinical Practice Guideline: liberation from mechanical ventilation in critically ill adults. Rehabilitation protocols, ventilator liberation protocols, and cuff leak tests. Am J Respir Crit Care Med 2017; 195 (01) 120-133
70 Gacouin A, Locufier M, Uhel F. , et al. Liver cirrhosis is independently associated with 90-day mortality in ARDS patients. Shock 2016; 45 (01) 16-21
71 Laffey JG, Bellani G, Pham T. , et al; LUNG SAFE Investigators and the ESICM Trials Group. Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study. Intensive Care Med 2016; 42 (12) 1865-1876
72 Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. ; Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342 (18) 1301-1308
73 Needham DM, Yang T, Dinglas VD. , et al. Timing of low tidal volume ventilation and intensive care unit mortality in acute respiratory distress syndrome. A prospective cohort study. Am J Respir Crit Care Med 2015; 191 (02) 177-185
74 Fan E, Del Sorbo L, Goligher EC. , et al; American Thoracic Society, European Society of Intensive Care Medicine, and Society of Critical Care Medicine. An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 195 (09) 1253-1263
75 Briel M, Meade M, Mercat A. , et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2010; 303 (09) 865-873
76 Santa Cruz R, Rojas JI, Nervi R, Heredia R, Ciapponi A. High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 2013; ;( (06) CD009098
77 Kocabayoglu P, Treckmann JW, Beckebaum S. , et al. Does long-term ventilation with PEEP > or = 10mbar influence graft-function in patients following liver transplantation?. Hepatogastroenterology 2010; 57 (101) 839-844
78 Saner FH, Olde Damink SW, Pavlaković G. , et al. How far can we go with positive end-expiratory pressure (PEEP) in liver transplant patients?. J Clin Anesth 2010; 22 (02) 104-109
79 Saner FH, Pavlaković G, Gu Y. , et al. Does PEEP impair the hepatic outflow in patients following liver transplantation?. Intensive Care Med 2006; 32 (10) 1584-1590
80 Wiedemann HP, Wheeler AP, Bernard GR. , et al; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354 (24) 2564-2575
81 Bellani G, Laffey JG, Pham T. , et al; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016; 315 (08) 788-800
82 Papazian L, Forel JM, Gacouin A. , et al; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363 (12) 1107-1116
83 Guérin C, Reignier J, Richard JC. , et al; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368 (23) 2159-2168
84 Audimoolam VK, McPhail MJ, Wendon JA. , et al. Lung injury and its prognostic significance in acute liver failure. Crit Care Med 2014; 42 (03) 592-600
85 Ali M, Wall WJ. Resolution of the adult respiratory distress syndrome following colectomy and liver transplantation. Chest 1990; 98 (04) 1032-1034
86 Matuschak GM, Shaw Jr BW. Adult respiratory distress syndrome associated with acute liver allograft rejection: resolution following hepatic retransplantation. Crit Care Med 1987; 15 (09) 878-881
87 Doyle HR, Marino IR, Miro A. , et al. Adult respiratory distress syndrome secondary to end-stage liver disease-successful outcome following liver transplantation. Transplantation 1993; 55 (02) 292-296
88 Abelmann WH, Frank NR, Gaensler EA, Cugell DW. Effects of abdominal distention by ascites on lung volumes and ventilation. AMA Arch Intern Med 1954; 93 (04) 528-540
89 Duranti R, Laffi G, Misuri G. , et al. Respiratory mechanics in patients with tense cirrhotic ascites. Eur Respir J 1997; 10 (07) 1622-1630
90 Angueira CE, Kadakia SC. Effects of large-volume paracentesis on pulmonary function in patients with tense cirrhotic ascites. Hepatology 1994; 20 (4 Pt 1): 825-828
91 Berkowitz KA, Butensky MS, Smith RL. Pulmonary function changes after large volume paracentesis. Am J Gastroenterol 1993; 88 (06) 905-907
92 Mayr U, Karsten E, Lahmer T. , et al. Impact of large volume paracentesis on respiratory parameters including transpulmonary pressure and on transpulmonary thermodilution derived hemodynamics: a prospective study. PLoS One 2018; 13 (03) e0193654
93 Karcz M, Bankey B, Schwaiberger D, Lachmann B, Papadakos PJ. Acute respiratory failure complicating advanced liver disease. Semin Respir Crit Care Med 2012; 33 (01) 96-110
94 Ede RJ, Gimson AE, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 1986; 2 (01) 43-51
95 Carney N, Totten AM, O'Reilly C. , et al. Guidelines for the management of severe traumatic brain Injury, fourth edition. Neurosurgery 2017; 80 (01) 6-15
96 AASLD Guidelines. Available at: http://www.aasld.org/practiceguidelines/Documents/AcuteLiverFailureUpdate2011.pdf . Accessed on: June 15, 2018
97 Davis DP, Meade W, Sise MJ. , et al. Both hypoxemia and extreme hyperoxemia may be detrimental in patients with severe traumatic brain injury. J Neurotrauma 2009; 26 (12) 2217-2223
98 Stolmeijer R, Bouma HR, Zijlstra JG, Drost-de Klerck AM, Ter Maaten JC, Ligtenberg JJM. A systematic review of the effects of hyperoxia in acutely ill patients: should we aim for less?. BioMed Res Int 2018; 2018: 7841295
99 Helmerhorst HJ, Roos-Blom MJ, van Westerloo DJ, de Jonge E. Association between arterial hyperoxia and outcome in subsets of critical illness: a systematic review, meta-analysis, and meta-regression of cohort studies. Crit Care Med 2015; 43 (07) 1508-1519
100 Asehnoune K, Mrozek S, Perrigault PF. , et al; BI-VILI study group. A multi-faceted strategy to reduce ventilation-associated mortality in brain-injured patients. The BI-VILI project: a nationwide quality improvement project. Intensive Care Med 2017; 43 (07) 957-970
101 Asehnoune K, Roquilly A, Cinotti R. Respiratory management in patients with severe brain injury. Crit Care 2018; 22 (01) 76
102 Boone MD, Jinadasa SP, Mueller A. , et al. The effect of positive end-expiratory pressure on intracranial pressure and cerebral hemodynamics. Neurocrit Care 2017; 26 (02) 174-181
103 Kredel M, Muellenbach RM, Hornung A. , et al. Hepatic effects of an open lung strategy and cardiac output restoration in an experimental lung injury. Acta Anaesthesiol Scand 2010; 54 (05) 632-642
104 Brienza N, Revelly JP, Ayuse T, Robotham JL. Effects of PEEP on liver arterial and venous blood flows. Am J Respir Crit Care Med 1995; 152 (02) 504-510
105 Girard TD, Kress JP, Fuchs BD. , et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008; 371 (9607): 126-134
106 Blackwood B, Burns KE, Cardwell CR, O'Halloran P. Protocolized versus non-protocolized weaning for reducing the duration of mechanical ventilation in critically ill adult patients. Cochrane Database Syst Rev 2014; ;( (11) CD006904
107 Hernández G, Vaquero C, González P. , et al. Effect of postextubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low-risk patients: a randomized clinical trial. JAMA 2016; 315 (13) 1354-1361
108 Ferrer M, Valencia M, Nicolas JM, Bernadich O, Badia JR, Torres A. Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial. Am J Respir Crit Care Med 2006; 173 (02) 164-170
109 Hernández G, Vaquero C, Colinas L. , et al. Effect of postextubation high-flow nasal cannula vs noninvasive ventilation on reintubation and postextubation respiratory failure in high-risk patients: a randomized clinical trial. JAMA 2016; 316 (15) 1565-1574
110 Estenssoro E, González F, Laffaire E. , et al. Shock on admission day is the best predictor of prolonged mechanical ventilation in the ICU. Chest 2005; 127 (02) 598-603
111 Seneff MG, Zimmerman JE, Knaus WA, Wagner DP, Draper EA. Predicting the duration of mechanical ventilation. The importance of disease and patient characteristics. Chest 1996; 110 (02) 469-479
112 Shin HJ, Chang JS, Ahn S. , et al. Clinical factors associated with weaning failure in patients requiring prolonged mechanical ventilation. J Thorac Dis 2017; 9 (01) 143-150
113 Lu HM, Chen L, Wang JD. , et al. Outcomes of prolonged mechanic ventilation: a discrimination model based on longitudinal health insurance and death certificate data. BMC Health Serv Res 2012; 12: 100
114 Damuth E, Mitchell JA, Bartock JL, Roberts BW, Trzeciak S. Long-term survival of critically ill patients treated with prolonged mechanical ventilation: a systematic review and meta-analysis. Lancet Respir Med 2015; 3 (07) 544-553
115 Aubier M, Viires N, Piquet J. , et al. Effects of hypocalcemia on diaphragmatic strength generation. J Appl Physiol (1985) 1985; 58 (06) 2054-2061
116 Aubier M, Murciano D, Lecocguic Y. , et al. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med 1985; 313 (07) 420-424
117 Dhingra S, Solven F, Wilson A, McCarthy DS. Hypomagnesemia and respiratory muscle power. Am Rev Respir Dis 1984; 129 (03) 497-498
118 Laghi F, Tobin MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med 2003; 168 (01) 10-48
119 Liposky JM, Nelson LD. Ventilatory response to high caloric loads in critically ill patients. Crit Care Med 1994; 22 (05) 796-802
120 Preiser JC, van Zanten AR, Berger MM. , et al. Metabolic and nutritional support of critically ill patients: consensus and controversies. Crit Care 2015; 19: 35
121 Huang CT, Lin HC, Chang SC, Lee WC. Pre-operative risk factors predict post-operative respiratory failure after liver transplantation. PLoS One 2011; 6 (08) e22689
122 Pedersen MR, Choi M, Brink JA, Seetharam AB. Pretransplant factors and associations with postoperative respiratory failure, ICU length of stay, and short-term survival after liver transplantation in a high MELD population. J Transplant 2016; 2016: 6787854
123 Knaak J, McVey M, Bazerbachi F. , et al. Liver transplantation in patients with end-stage liver disease requiring intensive care unit admission and intubation. Liver Transpl 2015; 21 (06) 761-767
124 Linecker M, Krones T, Berg T. , et al. Potentially inappropriate liver transplantation in the era of the “sickest first” policy - a search for the upper limits. J Hepatol 2017; S0168-8278(17)32430-3